A previous literature review indicated that there is little published experimental data that can be used to determine quantities such as bias, accuracy, reliability, and cost of common Nondestructive Evaluation (NDE) methods as far as their use on bridges is concerned. This study attempts to quantify these parameters for common bridge NDE methods through a four-round Delphi method survey with experts in the NDE bridge field. The survey results indicate that most commonly used bridge NDE methods tend to be underbiased and relatively reliable. Furthermore, the accuracy of commonly used bridge NDE methods tends to be relatively variable with the average test measuring a true response between 80% and 85% of the time. In general, it was shown by the participant responses that the more expensive the method was, the better the bias, accuracy, and reliability the method had, and vice versa. The information presented in this paper can serve as a starting point for characterizing different NDE methods for use in bridge management and inspection planning and identifies the type of information that is still needed. As such, this research has the potential to promote further research on this subject.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2uaaC5A
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Background Liver resection of benign, primary, and metastatic tumors is challenging and places patients at risk of postoperativ...
-
Publication date: Available online 8 April 2017 Source: Cortex Author(s): Jeremy Purcell, Rajani Sebastian, Richard Leigh, Samson Jarso,...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2p4oxom via IFTTT
-
With a highly professional, friendly and compassionate staff, Coral Springs Funeral Home is the first choice for hundreds of area families e...
-
OBJECTIVE: This study was aimed to explore the underlying genes associated with lung cancer (LC) by bioinformatics analysis. DATA AND METH...
-
La Traviata The soprano Diana Damrau gave her first performance as Violetta in Verdi’s “Traviata” as it returned to the Metropolitan Opera. ...
-
Though TRAIL has been hailed as a promising drug for tumour treatment, it has been observed that many tumour cells have developed escape mec...
-
Sheffield cancer patient becomes 1000th person to have surgery using 'high-tech robot' South Yorkshire Times As well as prost...
-
Biomarkers for Hearing Dysfunction: Facts and Outlook. ORL J Otorhinolaryngol Relat Spec. 2017 Feb 24;79(1-2):93-111 Authors: Rüttige...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου